Abeona Therapeutics
ABEO
#8122
Rank
โ‚น23.70 B
Marketcap
โ‚น437.50
Share price
0.00%
Change (1 day)
-14.18%
Change (1 year)

Revenue for Abeona Therapeutics (ABEO)

Revenue in 2025 (TTM): โ‚น34.28 Million

According to Abeona Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚น35.93 Million. In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of โ‚น0.29 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Abeona Therapeutics from 1999 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น34.28 M
2024 N/A-100%
2023 โ‚น0.29 B149.02%
2022 โ‚น0.11 B-47.6%
2021 โ‚น0.22 B-69.47%
2020 โ‚น0.73 B
2019 N/A-100%
2018 โ‚น27.12 M-49.24%
2017 โ‚น53.44 M-11.54%
2016 โ‚น60.41 M-12.59%
2015 โ‚น69.11 M17.89%
2014 โ‚น58.62 M-53.53%
2013 โ‚น0.12 B-47.68%
2012 โ‚น0.24 B146.79%
2011 โ‚น97.7 M353.32%
2010 โ‚น21.55 M31.97%
2009 โ‚น16.33 M16.77%
2008 โ‚น13.98 M
2004 โ‚น23.77 M-59.68%
2003 โ‚น58.96 M7.2%
2002 โ‚น55 M369.11%
2001 โ‚น11.72 M
1999 โ‚น0.73 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Taro Pharmaceutical
TARO
โ‚น54.87 B 152,607.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Merck
MRK
โ‚น5.770 T 16,058,650.00%๐Ÿ‡บ๐Ÿ‡ธ USA